End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.03 CNY | 0.00% | -1.47% | -27.40% |
May. 27 | Sichuan Goldstone Asia Pharmaceutical Inc. Approves Cash Dividend for 2023 | CI |
Apr. 26 | Sichuan Goldstone Asia Pharmaceutical Inc. Proposes Final Cash Dividend for 2023 | CI |
Sales 2022 | 1.24B 172M | Sales 2023 | 1.21B 167M | Capitalization | 4.44B 614M |
---|---|---|---|---|---|
Net income 2022 | 219M 30.26M | Net income 2023 | 126M 17.41M | EV / Sales 2022 | 4 x |
Net cash position 2022 | 494M 68.23M | Net cash position 2023 | 575M 79.44M | EV / Sales 2023 | 3.2 x |
P/E ratio 2022 |
25.2
x | P/E ratio 2023 |
35.7
x | Employees | 1,962 |
Yield 2022 * |
-
| Yield 2023 |
0.99% | Free-Float | 38.99% |
1 week | -1.47% | ||
Current month | -5.86% | ||
1 month | -12.72% | ||
3 months | -11.47% | ||
6 months | -30.72% | ||
Current year | -27.40% |
Managers | Title | Age | Since |
---|---|---|---|
Bao Kang Wei
CEO | Chief Executive Officer | 56 | 19-12-08 |
Qing Guo Wang
DFI | Director of Finance/CFO | 49 | 22-08-24 |
Zhi Yong Zheng
BRD | Director/Board Member | 56 | 17-10-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yi Xi Kuai
BRD | Director/Board Member | 66 | 04-06-30 |
Qiang Lin
BRD | Director/Board Member | 60 | 04-06-30 |
Run Xiu Li
BRD | Director/Board Member | 55 | 04-06-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 8.03 | 0.00% | 4 224 700 |
24-06-11 | 8.03 | +3.21% | 4,605,701 |
24-06-07 | 7.78 | +3.87% | 5,979,080 |
24-06-06 | 7.49 | -5.31% | 7,193,500 |
24-06-05 | 7.91 | -2.94% | 3,491,800 |
End-of-day quote Shenzhen S.E., June 11, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.40% | 445M | |
+19.64% | 43.03B | |
+23.86% | 22.7B | |
+17.44% | 15.07B | |
+23.64% | 14.77B | |
+59.16% | 13.05B | |
-0.05% | 6.79B | |
-14.19% | 6.58B | |
-8.87% | 5.73B | |
+13.42% | 5.5B |
- Stock Market
- Equities
- 300434 Stock